SOURCE: Proteonomix

Proteonomix

April 22, 2010 12:15 ET

Proteonomix, Inc. (PROT) Announces That It Has Cleared Comments in Its Registration Statement Filed With the Securities and Exchange Commission and Is Applying for a Listing on the OTCBB

MOUNTAINSIDE, NJ--(Marketwire - April 22, 2010) -  Proteonomix, Inc. (PINKSHEETS: PROT) announces it has received a no comment letter from the Securities and Exchange Commission on its registration statement on Form 10 pursuant of the Securities Exchange Act of 1934. The no comment letter permits the company to file with FINRA through a broker-dealer for a listing of its common stock on the OTC Bulletin Board.  Proteonomix is supplying documentation to a registered broker-dealer for a listing on its behalf.

The Company has traded on the Pink Sheets and more recently on the OTCQB. Since October 5, 2009, it has filed reports with the SEC, including quarterly reports on Form 10-Q, an annual report on Form 10-K and reports on Form 8-K. In addition, its affiliates have reported their acquisition and sale of Proteonomix securities on Form 3 and Form 4.

Michael Cohen, President, stated: "We have always tried to be transparent in the disclosure of our business and finances and intend to be current in reports filed with the SEC. Our receipt of this SEC no-comment letter on our registration statement allows us the opportunity to list on the OTCBB market. An OTCBB listing will add to the credibility of the disclosure of our technological and therapeutic advances, and also exposes our company to clients of firms that do not presently allow their representatives to recommend our common stock. Finally, a listing on the OTCBB will provide a greater opportunity for institutions to become involved in PROT."

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteonomix has facilities at a number of academic institutions. Its subsidiary, Proteoderm has developed a line of anti-aging cosmetics. Please visit www.proteonomix.com, www.proteoderm.com, www.otcqb.com and www.sec.gov.

Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Proteonomix, Inc. cautions that statements made in this press release relating to its OTCBB listing constitute forward-looking statements and makes no guarantee of future performance. Actual results or developments may differ materially from projections. Forward-looking statements are based on estimates and opinions of management at the time statements are made.

Contact Information

  • Contact:
    Michael Cohen
    Proteonomix, Inc.
    (973) 544-6116